Company Filing History:
Years Active: 2025
Title: Thomas Gentinetta: Innovator in Hemopexin Formulations
Introduction
Thomas Gentinetta is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of hemopexin formulations. His work is characterized by a focus on creating stable liquid formulations that can have important applications in medical science.
Latest Patents
Gentinetta holds a patent for a stable liquid formulation of purified hemopexin. This formulation includes a hemopexin content of at least 50 mg/mL, at least 15 mM phosphate buffer, a pH range from 5.8 to 8, and at least 50 mM sodium chloride. The innovative aspects of this patent highlight its potential uses in therapeutic applications.
Career Highlights
He is currently associated with CSL Behring AG, a company known for its focus on biopharmaceuticals. His work at CSL Behring AG has allowed him to further his research and development efforts in the field of hemopexin and its applications.
Collaborations
Throughout his career, Gentinetta has collaborated with several professionals, including Nathan Brinkman and David Boerema. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Thomas Gentinetta is a distinguished inventor whose work in hemopexin formulations has the potential to impact medical science significantly. His contributions, along with his collaborations, continue to drive innovation in the field.